semaglutide green bay Medical weight loss injections with GLP-1 Semaglutide (ozempic) before & after

1992 Jul 21;218(1):117-21

427 Cardiac energy metabolism is further regulated by hormones

The peptide is typically delivered subcutaneously (under the skin) or through an intramuscular injection

These results pale against GLP-1 data demonstrating 15-22% body weight reduction over longer periods, with cardiovascular and metabolic benefits

For GLP-1 medications, insurers may require evidence that the patient has tried other treatments or that the medication is essential for managing weight loss in the presence of other conditions like type 2 diabetes, hypertension, or cardiovascular disease

If experiencing symptoms, other hormonal imbalances may be responsible